Recently Updated
- 07/01/2011
- Map of Misoprostol Approval
- 06/02/2011
- Map of Mifepristone Approval
- 06/01/2011
- List of Mifepristone Approval
- 06/01/2011
- Misoprostol for Treatment of Postpartum Hemorrhage
- 11/26/2010
- Postpartum Hemorrhage Program Brief
Misoprostol for Incomplete Abortion in Guatemala
Misoprostol for the prevention and treatment of postpartum hemorrhage
The comparative safety of legal induced abortion and childbirth in the United States
Two doses of buccal misoprostol following mifepristone
Abortion: What is the problem?
Misoprostol for postpartum hemorrhage: Moving from evidence to practice
Facility and personnel factors influencing magnesium sulfate use for eclampsia and pre-eclampsia
Oral Misoprostol for the Management of Incomplete Abortion in Ecuador
The Product Problem: Pathways for Making Misoprostol Available for Postpartum Hemorrhage
Postpartum hemorrhage: Moving from Research to Reality
Treatment approaches for preeclampsia in low-resource settings
Mifepristone and Misoprostol Compared With Misoprostol Alone for Second-trimester Abortion
Review of the Literature on Patient Satisfaction with Early Medical Abortion
Misoprostol for Treatment of Postpartum Hemorrhage
Comparing two early medical abortion regimens: Mifepristone+misoprostol vs. misoprostol alone
Medical abortion for adolescents
Introduction and provision of medical abortion: A tale of two countries
Exploration of a new procedure for sterilization
Pericoital Oral Contraception with Levonorgestrel: A Systematic Review
Misoprostol to augment routine active management of the third stage of labor
Ultrasound for eligibility assessment for medical abortion
Misoprostol for PPH prevention in homebirths in Pakistan
Oral misoprostol as an alternative to surgical management for incomplete abortion in Ghana
Buccal vs. sublingual misoprostol after mifepristone for medical abortion
Self-induction of abortion among women in the United States
Alternatives to routine ultrasound for eligibility assessment prior to medical abortion
Abortion With Self-Administered Misoprostol: A Guide For Women
Sublingual misoprostol vs. MVA for the treatment of incomplete abortion in Egypt
Medical abortion: Outcomes in a family medicine setting
Unsafe Abortion and Strategies to Reduce its Impact on Women’s Lives
Misoprostol as adjunct treatment for treatment of postpartum haemorrhage
What measured blood loss tells us about postpartum bleeding
High fever following postpartum administration of sublingual misoprostol
ICMA Third International Conference
Home administration of misoprostol for early medical abortion in India
Alternatives to Routine Follow-Up for Early Medical Abortion
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 2/2
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 1/2
Annotated Bibliography - Mifepristone Medical Abortion
Comparison of serum markers for thrombophilia and autoimmune disease
Misoprostol, Abortion, and the Law
Guidebook on Misoprostol for Treatment of Incomplete Abortion
Acceptability and feasibility of medical abortion in Nepal
Knowledge, attitudes, and practice of abortion among women and doctors in Armenia
Increasing women’s choices in medical abortion in Turkey
Oral vs. sublingual misoprostol (400 mcg) following 200 mg mifepristone
Sublingual misoprostol for incomplete abortion
Non-physician clinicians can safely provide first trimester medical abortion
Misoprostol for the Prevention of Postpartum Hemorrhage: Findings from Research in Pakistan
Sublingual misoprostol after mifepristone
Abortion and sex determination
Two distinct oral routes of misoprostol in mifepristone medical abortion
Expanding Choice in Abortion Services in Armenia
Abortion in the Middle East and North Africa
Misoprostol in addition to routine treatment of postpartum hemorrhage in Pakistan
Comment on Misoprostol impairs female reproductive tract innate immunity against C. sordellii
Integrating medical abortion into safe abortion services in South Africa
Fever after treatment of postpartum hemorrhage
Misoprostol for the Treatment of Postpartum Hemorrhage: Findings from Clinical Research Trials
Social Science Research Activities Brief
Policy and Advocacy Activities Brief
Pregnancy Failure and Miscarriage Program Brief
Blood Loss After Vaginal Delivery
Community-based kangaroo mother care to prevent neonatal and infant mortality
Supervision for use of mifepristone medical abortion
STIs/ HIV/ Infectious Disease Program Brief
Training and Education Activities Brief
Technical Assistance Activities Brief
Materials Development Activities Brief
Misoprostol to treat missed abortion in the first trimester
Treatment of incomplete abortion and miscarriage with misoprostol
Prevention of postpartum hemorrhage with misoprostol
Treatment of postpartum hemorrhage with misoprostol
Choices for Medical Abortion Introduction in Brazil, Colombia, Mexico and Peru
Misoprostol for incomplete abortion in Burkina Faso
Misoprostol for incomplete abortion in Tanzania
Medical Abortion Program Brief
Perspectives on reproductive decision-making amongst HIV-infected individuals
Postpartum Hemorrhage Program Brief
Misoprostol for incomplete abortion in Mozambique
Reference List - Misoprostol for Prevention of Postpartum Hemorrhage
Misoprostol for Prevention of Postpartum Hemorrhage
Reproductive intentions among HIV-positive women and men
The supreme court and the partial-birth abortion ban act of 2003
Assessment of pregnancy duration among termination of pregnancy clients in South Africa
Methotrexate compared to misoprostol alone for early medical abortion
Can mifepristone medical abortion be simplified?
Mifepristone for late first trimester abortion
Alternatives to mifepristone for early medical abortion
Are two doses of misoprostol after mifepristone for early abortion better than one?
Use of sequential serum hCG and sonography for medical abortion only when indicated
Misoprostol for uterine evacuation in induced abortion and pregnancy failure
Clostridium sordellii infection in medical abortion
FAQs on Fatal Infection and Medical Abortion - Technical Version